Ketoprofene Biogaran (Ketoprofen)

Ketoprofen blocks the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for producing prostaglandins. By lowering prostaglandin levels, the drug diminishes the inflammatory response, reduces pain signals, and helps lower fever in affected tissues.

The appropriate dose of Ketoprofene Biogaran is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Ketoprofen is generally avoided during the third trimester of pregnancy because of potential fetal cardiovascular effects. It should be used only if clearly needed and prescribed by a qualified clinician. Limited data exist for breastfeeding; the drug may pass into milk, so a risk‑benefit assessment is required.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoprofen shares the core COX‑inhibiting mechanism of other NSAIDs but has a relatively rapid onset of analgesia and a slightly higher potency for pain relief in musculoskeletal conditions. Its safety profile is similar, with comparable gastrointestinal and renal risks, though individual tolerability may vary.

Ketoprofene Biogaran should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Ketoprofene Biogaran is supplied as oral tablets that are taken by mouth with a full glass of water. It may be taken with or without food, although taking it with meals can help reduce gastrointestinal discomfort.

Serious risks include gastrointestinal bleeding or ulceration, severe renal impairment, hepatic dysfunction, cardiovascular thrombotic events, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored for signs of these conditions, especially during long‑term therapy.

Ketoprofene Biogaran is contraindicated in individuals with known hypersensitivity to ketoprofen or any NSAID, those with active gastrointestinal ulceration or bleeding, severe renal or hepatic impairment, and patients in the third trimester of pregnancy. Caution is also advised for patients with uncontrolled hypertension or heart failure.